Patrick Whitlow, M.D.

Patrick L. Whitlow, MD, is Associate Director for Device Trials of C5Research and is Director of Interventional Cardiology in the Department of Cardiovascular Medicine.

Dr. Whitlow’s specialty interests include cardiac catheterization, peripheral vascular and coronary angiography, coronary and peripheral vascular stenting, new interventional devices, percutaneous mitral valve repair and aortic valve replacement.

Dr. Whitlow’s research interests are focused on new cardiovascular device trials. He has been the national Principal Investigator in many trials and is experienced in presenting new device applications to the FDA. Current research includes studies with drug-eluting stents, carotid revascularization, chronic total occlusions, percutaneous aortic valve replacement, percutaneous mitral valve repair, renal stenting and percutaneous lower-extremity revascularization.

He has authored or coauthored over 30 book chapters and 170 articles in leading medical journals.
After receiving his medical degree from Duke University School of Medicine, Dr. Whitlow completed residency and internship training in internal medicine at Dallas County Parkland Hospital and a fellowship in cardiovascular medicine at the University of Alabama Hospital, Birmingham. He was Catheterization Laboratory Director at University of Alabama at Birmingham before joining Cleveland Clinic in 1986.

Cardiac catheterization and angiography, coronary angioplasty, new coronary interventional devices, thrombolytic therapy.

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 8/5/2008, Dr. Whitlow has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Equity.  Dr. Whitlow owns stock or stock options in the following companies for activities as a founder, inventor, or consultant:

• ICON
• Medlogics
• Medtronic, Inc.

Fiduciary Role.  Dr. Whitlow serves in a fiduciary capacity, such as an officer or director, for the following companies or other entities:

• Medlogics, Inc.

( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)